Elson C E, Kufe D, Johnston W W
Department of Pathology, Research Medical Center, Kansas City, Missouri.
Anal Quant Cytol Histol. 1993 Jun;15(3):171-8.
Paraffin blocks of all axillary lymph nodes from 97 patients with an initial histologic diagnosis of infiltrating ductal carcinoma and negative axillary nodes were recut and stained with two monoclonal antibodies, AE/AE3 (antikeratin) and DF3 (developed against breast cancer cells and reactive with a glycoprotein tumor-associated antigen). Immunohistochemical staining detected occult micrometastases in 20 patients (20.6%). No patient had more than three lymph nodes involved by tumor. Review of the original hematoxylin and eosin-stained sections revealed that foci of tumor were initially overlooked in nine of these cases (9.3%). In the remaining 11 cases (11.3%) the metastatic foci were encountered in the process of recutting the paraffin blocks for immunohistochemical studies. AE1/AE3 proved to be the more effective of the two antibodies in staining micrometastases. After a mean follow-up period of 5.7 years, no significant decrease in survival or increase in tumor recurrence was detected for patients with occult micrometastases as compared to those patients without micrometastases.
对97例最初组织学诊断为浸润性导管癌且腋窝淋巴结阴性的患者的所有腋窝淋巴结石蜡块进行重新切片,并用两种单克隆抗体AE/AE3(抗角蛋白)和DF3(针对乳腺癌细胞产生且与一种糖蛋白肿瘤相关抗原发生反应)进行染色。免疫组化染色在20例患者(20.6%)中检测到隐匿性微转移。没有患者有超过三个淋巴结被肿瘤累及。对原始苏木精和伊红染色切片的复查显示,在这些病例中有9例(9.3%)肿瘤灶最初被遗漏。在其余11例(11.3%)中,转移性病灶是在为免疫组化研究重新切片石蜡块的过程中发现的。AE1/AE3被证明是两种抗体中在染色微转移方面更有效的一种。在平均随访5.7年后,与无微转移的患者相比,隐匿性微转移患者的生存率没有显著下降,肿瘤复发率也没有增加。